Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
There are multiple ways to get cash for paying off debts. Explore these strategies to alleviate your financial pressure.
22,884 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
BMO Capital Markets cuts Lithium Americas' price target to $4.50, citing 15% capex inflation at Thacker Pass and ongo...
This in-depth guide helps investors decode McDonald's 2026 earnings by examining the Q1 transcript, key drivers, and ...
A little-known rule may cap a household's Social Security checks when there are dependents. Here’s how the family max...
Warren Buffett's successor, Greg Abel, is drawing new attention as recent 13F filings hint at a shift in Berkshire's ...
Big Tech’s AI investments are driving a potential $700B spend this year. This guide breaks down who wins, how to inve...
With Johnson & Johnson stock hovering near mid-230s, investors are weighing if a $300 target is in reach this year as...
As peace hopes buoy mood, major indices climb and big tech names surge. Discover what drove the stock market today, j...
A seismic shift in how the Fed communicates could redefine market expectations. This piece examines kevin warsh shift...
In 2026, Sharplink makes its first Ethereum purchase, signaling a calculated pivot in treasury strategy. This article...
Micron posts strong AI-driven memory demand and rising cloud bookings, while Apple relies on devices and services to ...
When a Planet Labs CEO sells shares, investors take note. This article breaks down what the move could signal, how to...